Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA5 | P22460 | 11/20 | 0.51 |
| ▸ | FDPS | P14324 | 5/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 6/20 | 0.46 |
| ▸ | BTN3A1 | O00481 | 1/20 | 0.45 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.45 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13746036 | 0.77 | FDPS (0.53) | KCNA5FDPSBTN3A1PDE3ACYP19A1 | |
| SCHEMBL15533205 | 0.76 | FDPS (0.53) | KCNA5FDPSBTN3A1PDE3ACYP19A1 | |
| SCHEMBL4725467 | 0.75 | FDPS (0.51) | KCNA5FDPSBTN3A1PDE3ACYP19A1 | |
| SCHEMBL20148789 | 0.74 | CYP3A4 (0.62) | KCNA5KCNH2CYP19A1 | |
| SCHEMBL9850885 | 0.71 | LMNA (0.51) | FDPSBTN3A1PDE3ACYP19A1 | |
| SCHEMBL11594033 | 0.71 | FDPS (0.47) | KCNA5FDPSBTN3A1PDE3ACYP19A1 | |
| SCHEMBL15038326 | 0.71 | FDPS (0.47) | KCNA5FDPSBTN3A1PDE3ACYP19A1 | |
| SCHEMBL19627972 | 0.71 | CYP19A1 (0.57) | KCNA5CYP19A1 | |
| SCHEMBL11624747 | 0.70 | KCNA5 (0.61) | KCNA5KCNH2 | |
| Water SCHEMBL29532583 | 0.70 | LMNA (0.50) | FDPSBTN3A1PDE3ACYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2001082903-A1 | ENTERIC COATED FORMULATION OF BISPHOSPHONIC ACID COMPOUNDS AND ASSOCIATED THERAPEUTIC METHODS | LIPOCINE, INC. (US) | 2001-11-08 | — | — | WO | disclosed |